NCT05103319View on ClinicalTrials.gov

Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions

CompletedOBSERVATIONAL
Enrollment

319

Participants

Timeline

Start Date

September 7, 2021

Primary Completion Date

January 30, 2022

Study Completion Date

January 30, 2022

Conditions
Chronic Pain
Interventions
OTHER

Data collection for statistical analysis to identify patterns of treatment response/ non-response

All data are restricted from the patient physical and electronic record of the Pain Management-Unit of the University Hospital Basel. No external data sources will be used. Records will be screened from 2012- May 2021. Variables collected are e.g. demography, medical diagnosis, psychological diagnosis, infusion therapy, medication, pain.

Trial Locations (1)

4031

Department of Anesthesiology, University of Basel (USB), Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions | Biotech Hunter | Biotech Hunter